Janney Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $18.6M | Sell |
81,596
-18,544
| -19% | -$4.22M | 1.17% | 22 |
|
|
2025
Q3 | $23.2M | Sell |
100,140
-457
| -0.5% | -$93.1K | 1.44% | 12 |
|
|
2025
Q2 | $18.7M | Sell |
100,597
-995
| -1% | -$185K | 1.2% | 16 |
|
|
2025
Q1 | $21.3M | Sell |
101,592
-5,160
| -5% | -$1M | 1.46% | 12 |
|
|
2024
Q4 | $19M | Sell |
106,752
-1,363
| -1% | -$251K | 1.26% | 15 |
|
|
2024
Q3 | $21.4M | Sell |
108,115
-964
| -0.9% | -$180K | 1.44% | 11 |
|
|
2024
Q2 | $18.7M | Sell |
109,079
-5,196
| -5% | -$861K | 1.32% | 12 |
|
|
2024
Q1 | $20.8M | Sell |
114,275
-4,787
| -4% | -$825K | 1.38% | 10 |
|
|
2023
Q4 | $18.5M | Sell |
119,062
-24,946
| -17% | -$3.64M | 1.24% | 17 |
|
|
2023
Q3 | $21.5M | Buy |
144,008
+1,377
| +1% | +$202K | 1.65% | 13 |
|
|
2023
Q2 | $19.2M | Buy |
142,631
+2,942
| +2% | +$431K | 1.33% | 16 |
|
|
2023
Q1 | $22.3M | Buy |
139,689
+2,754
| +2% | +$421K | 1.67% | 11 |
|
|
2022
Q4 | $22.1M | Buy |
136,935
+5,006
| +4% | +$768K | 1.58% | 13 |
|
|
2022
Q3 | $17.7M | Buy |
131,929
+1,789
| +1% | +$257K | 1.44% | 17 |
|
|
2022
Q2 | $19.9M | Buy |
130,140
+327
| +0.3% | +$50K | 1.6% | 17 |
|
|
2022
Q1 | $21M | Buy |
129,813
+1,113
| +0.9% | +$162K | 1.5% | 19 |
|
|
2021
Q4 | $17.4M | Sell |
128,700
-1,358
| -1% | -$160K | 1.13% | 29 |
|
|
2021
Q3 | $14M | Buy |
130,058
+21,581
| +20% | +$2.47M | 0.94% | 36 |
|
|
2021
Q2 | $12.2M | Sell |
108,477
-626
| -0.6% | -$70.5K | 0.78% | 48 |
|
|
2021
Q1 | $11.8M | Sell |
109,103
-2,065
| -2% | -$221K | 0.78% | 46 |
|
|
2020
Q4 | $11.9M | Sell |
111,168
-5,414
| -5% | -$520K | 0.82% | 46 |
|
|
2020
Q3 | $10.2M | Buy |
116,582
+396
| +0.3% | +$37.3K | 0.7% | 58 |
|
|
2020
Q2 | $11.4M | Buy |
116,186
+109,135
| +1,548% | +$9.61M | 0.79% | 44 |
|
|
2020
Q1 | $537K | Sell |
7,051
-83
| -1% | -$7.07K | 0.04% | 123 |
|
|
2019
Q4 | $632K | Hold |
7,134
| – | – | 0.03% | 133 |
|
|
2019
Q3 | $540K | Sell |
7,134
-359
| -5% | -$24.6K | 0.03% | 134 |
|
|
2019
Q2 | $545K | Hold |
7,493
| – | – | 0.03% | 124 |
|
|
2019
Q1 | $604K | Sell |
7,493
-789
| -10% | -$64.5K | 0.03% | 120 |
|
|
2018
Q4 | $764K | Sell |
8,282
-11
| -0.1% | -$967 | 0.04% | 116 |
|
|
2018
Q3 | $784K | Buy |
8,293
+672
| +9% | +$63.7K | 0.03% | 119 |
|
|
2018
Q2 | $706K | Buy |
7,621
+232
| +3% | +$22.7K | 0.03% | 121 |
|
|
2018
Q1 | $699K | Buy |
7,389
+207
| +3% | +$22.7K | 0.03% | 119 |
|
|
2017
Q4 | $694K | Sell |
7,182
-572
| -7% | -$53.9K | 0.03% | 122 |
|
|
2017
Q3 | $689K | Buy |
7,754
+87
| +1% | +$6.62K | 0.03% | 119 |
|
|
2017
Q2 | $555K | Sell |
7,667
-357
| -4% | -$24K | 0.03% | 115 |
|
|
2017
Q1 | $522K | Sell |
8,024
-19
| -0.2% | -$1.2K | 0.02% | 121 |
|
|
2016
Q4 | $503K | Buy |
8,043
+382
| +5% | +$23.3K | 0.02% | 128 |
|
|
2016
Q3 | $483K | Buy |
7,661
+726
| +10% | +$47K | 0.02% | 123 |
|
|
2016
Q2 | $429K | Buy |
+6,935
| New | +$423K | 0.02% | 127 |
|
|
2016
Q1 | – | Sell |
-7,935
| Closed | -$470K | – | 149 |
|
|
2015
Q4 | $470K | Sell |
7,935
-115
| -1% | -$6.62K | 0.02% | 146 |
|
|
2015
Q3 | $438K | Buy |
+8,050
| New | +$524K | 0.02% | 145 |
|
|
2015
Q2 | – | Sell |
-7,650
| Closed | -$448K | – | 72 |
|
|
2015
Q1 | $448K | Buy |
7,650
+350
| +5% | +$21.1K | 0.02% | 180 |
|
|
2014
Q4 | $478K | Sell |
7,300
-53
| -0.7% | -$3.34K | 0.03% | 151 |
|
|
2014
Q3 | $425K | Buy |
7,353
+242
| +3% | +$13.4K | 0.03% | 153 |
|
|
2014
Q2 | $401K | Buy |
7,111
+880
| +14% | +$46.2K | 0.02% | 158 |
|
|
2014
Q1 | $320K | Buy |
6,231
+1,500
| +32% | +$75.8K | 0.02% | 167 |
|
|
2013
Q4 | $250K | Sell |
4,731
-255
| -5% | -$12.5K | 0.02% | 164 |
|
|
2013
Q3 | $223K | Hold |
4,986
| – | – | 0.02% | 199 |
|
|
2013
Q2 | $206K | Buy |
+4,986
| New | +$218K | 0.02% | 156 |
|
Other funds holding ABBV
Janney Capital Management's ABBV Position: Q4 2025 in Review
Janney Capital Management reduced its AbbVie (ABBV) stake by 19% in Q4 2025, selling an estimated $4.22M and leaving 81,596 shares worth $18.6M. The position accounts for 1.17% of the portfolio, ranked #22.
Janney Capital Management first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $23.2M in Q3 2025. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.
- Janney Capital Management held 81,596 shares of AbbVie worth $18.6M as of Q4 2025.
- Janney Capital Management sold 18,544 AbbVie shares in Q4 2025, an estimated $4.22M.
- AbbVie made up 1.17% of Janney Capital Management's portfolio in Q4 2025, its #22 holding.
- Janney Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
- Janney Capital Management's AbbVie position peaked at $23.2M in Q3 2025.
- 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.
Based on Janney Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.